We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current KOOL market cap is 16.12M. The company's latest EPS is USD -5.7300 and P/E is -0.90.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.12M | 2.68M | 2.57M | 2.27M | 2.19M |
| Operating Income | -2.02M | -1.53M | -1.05M | -1.73M | -1.56M |
| Net Income | -3.24M | -3.43M | -5.09M | -2.26M | -3.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.05M | 9.74M | 9.29M | 10.48M | 9.45M |
| Operating Income | -4.73M | -8.9M | -7.23M | -6.19M | -8.61M |
| Net Income | -9.5M | -16.35M | -11.38M | -11.27M | -17.98M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20.09M | 19.39M | 19.75M | 17.61M | 15.92M |
| Total Liabilities | 15.83M | 16.06M | 14.74M | 14.98M | 12.66M |
| Total Equity | 4.27M | 3.32M | 5.01M | 2.63M | 3.26M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 15.21M | 20.86M | 20.65M | 19.39M | 11.23M |
| Total Liabilities | 14.3M | 14.99M | 17.26M | 16.06M | 14.82M |
| Total Equity | 916k | 5.87M | 3.4M | 3.32M | -3.58M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.1M | -7.28M | -615k | -1.43M | -1.68M |
| Investing | -308k | -400k | -771k | -1.36M | -1.54M |
| Financing | 3.04M | 4.59M | 3.06M | 3.06M | 3.06M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.26M | -14.39M | -6.62M | -7.28M | -3.72M |
| Investing | -182k | -23k | -93k | -400k | -1.73M |
| Financing | 4.2M | 17.42M | 6.83M | 4.59M | 3.28M |
| Market Cap | 16.12M |
| Price to Earnings Ratio | -0.90 |
| Price to Sales Ratio | 1.71 |
| Price to Cash Ratio | 8.06 |
| Price to Book Ratio | -4.5 |
| Dividend Yield | - |
| Shares Outstanding | 3.14M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.92 (36.78%) |
| Company Name | Cesca Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.thermogenesis.com |
| Industry | lab apparatus and furniture (3821) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
